Understanding the Limitations of Defining Treatment Failure
Overview
This report discusses the complexities of defining treatment failure in anti-VEGF therapy for neovascular age-related macular degeneration (nAMD).
Background
The concept of treatment failure in nAMD is prevalent in clinical practice, yet the terminology used lacks standardization and does not fully capture the underlying biological mechanisms.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
- Persistent or recurrent exudation may indicate residual disease activity rather than treatment failure.
- Durability of treatment response reflects distinct biological states of choroidal neovascularization (CNV).
- Mechanism-Matched Endotypes (MME) framework links treatment behavior to underlying biological mechanisms.
- Visible exudation is a threshold event, not a direct measure of biological activity.
- Patterns of response to therapy can inform the understanding of underlying disease mechanisms.
Clinical Implications
Clinicians should consider the biological mechanisms behind treatment responses rather than solely relying on traditional definitions of treatment failure.
Conclusion
Reframing treatment response in terms of biological mechanisms can enhance understanding and management of nAMD.
Related Resources & Content
- The ASCO Post, 2014 -- ECOG E4402/RESORT Trial: When ‘Black and White’ Results Are Actually Gray
- Blood Cancer Journal, 2025 -- Clarifying the Concept of 'Intention' in Survival Outcomes for Intention-to-Treat Analysis in CAR T-Cell Therapy
- Bone Marrow Transplantation, 2021 -- Designing Clinical Trials: Key Endpoints and Outcome Interpretation
- Age-Related Macular Degeneration Preferred Practice Pattern®, Oregon Health & Science University
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - ScienceDirect
- Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis - ScienceDirect
- Harmonization of Terminology in Focal Therapy for Prostate Cancer: Findings from a Delphi Consensus Initiative
- Age-Related Macular Degeneration Preferred Practice Pattern® - Oregon Health & Science University
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial - ScienceDirect
- Persistence of Retinal Fluid after Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis - ScienceDirect
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
